Skip to main content
Medical information Clinical review pending

Infection Testing

Febrile Agglutinins Panel Combined Brucella Widal and Weil Felix Tests Panel Test

This panel helps identify infections causing fever, such as Brucella and Salmonella, by detecting specific antibodies in the blood. It combines tests for typhoid and rickettsial infections.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (serum)
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test.
Test priceKSh 2,878

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Febrile Agglutinins Panel Combined Brucella Widal and Weil Felix Tests Panel Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained or persistent fever
  • ✓Symptoms suggestive of typhoid fever
  • ✓Symptoms suggestive of brucellosis
  • ✓Exposure to livestock or unpasteurized dairy
  • ✓Travel to areas where these infections are common
  • ✓Monitoring response to treatment for these infections
02

In plain language

What this test helps you understand

This test aids in the diagnosis of infections associated with fever, including brucellosis, typhoid fever, and potentially rickettsial infections, by detecting specific antibodies in the patient's blood.
The Febrile Agglutinins Panel Test is a diagnostic tool used to help identify specific infections that can cause fever. It looks for antibodies (agglutinins) produced by your immune system in response to certain bacterial infections, including Brucella (causing brucellosis) and Salmonella (causing typhoid fever). This test combines several related tests to provide a broader picture of potential infections.

This panel measures antibodies against specific strains of Brucella and Salmonella, as well as antigens used in the Weil Felix test for rickettsial infections. It can help your doctor understand the possible cause of your fever, especially if you have risk factors like exposure to animals or travel to certain areas.

This test is useful for individuals experiencing persistent or unexplained fever, particularly when symptoms suggest a bacterial infection. It aids in guiding appropriate treatment decisions and helps prevent potential complications from untreated infections. Results are interpreted by a qualified healthcare professional in the context of your clinical presentation.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test.
SampleBlood sample (serum)
MethodologyAgglutination tests
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects antibodies, which may take time to develop after infection. Results can be influenced by previous infections, vaccinations, or cross-reactivity with other conditions. A positive result indicates exposure or infection but does not confirm active disease. Confirmation with other tests may be necessary.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects antibodies (agglutinins) in your blood that indicate potential infection with bacteria like Brucella (causing brucellosis) and Salmonella (causing typhoid fever), as well as potentially rickettsial infections.
No special preparation, including fasting, is required for this test.
A healthcare professional will interpret the results based on the specific antibodies detected, your symptoms, medical history, and other relevant tests. A positive result suggests possible infection.
Sample collection services are available across major cities in Kenya. Please confirm availability for your specific location when booking.
Turnaround time varies. Please confirm the expected turnaround time with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp